Escolar Documentos
Profissional Documentos
Cultura Documentos
BS PHARMACY 4A
Self-Directed Activity - Generics Act of 1988, A.O. 62, A.O. 63, A.O. 90
Please refer to pages 169-179 of the PDF “PNDF – A.O. 63 s. 1990” for answers to the
following questions:
Dangerous drugs refer to either prohibited drugs or regulated drugs which require a
special prescription form, the use of which is monitored by the by the Dangerous Drug
Board.
Prohibited drugs include "opium and its active components and derivatives such as
heroin and morphine; coca leaf and its derivatives, principally cocaine, alpha and beta
Eucaine, hallucinogenic drugs, such as mescaline lysergic acid diethylamide (LSD) and
other substances producing similar effects; Indian hemp and its derivatives; all preparations
made from any of the foregoing; and other drugs, whether natural or synthetic, with the
physiological effects of a narcotic drug.
Violative prescriptions
Where generic name is not written.
Where the generic name is not legible and a brand name which is legible is
written.
Where the brand name is indicated and instructions added (such as the
phrase "no substitution") which tend to obstruct, hinder or prevent proper generic
dispensing.
Erroneous prescriptions
Where the brand name precedes the generic name
Where the generic name is the one in parenthesis
Where the brand name is not in parenthesis
Where more than one drug product is prescribed on one prescription form.
Impossible prescriptions
When only the generic name is written but it is not legible
When the generic name does not correspond to the brand name
When both the generic name and the brand name are not legible
When the drug product prescribed is not registered with the BFAD
Actions that should be done when receiving Impossible prescriptions:
6. What are the different violations on the part of dispensers and outlets in response to
A.O. 63 s. 1990?
A.O 90 s. 1990 talks about the request of prescribing doctors to allow them to
write the name of more than one drug product on the same page of a prescription form
for a particular patient and it also no longer regards a prescription form with more than
one drug product as erroneous.